Cart
sales@molnova.com
AM-2232
CAS No. 335161-19-8
AM-2232( AM 2232 | AM2232 | UNII-40KCH8YIKP )
Catalog No. M27408 CAS No. 335161-19-8
AM-2232 is a potent and unselective agonist of the cannabinoid receptors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 128 | Get Quote |
|
| 5MG | 177 | Get Quote |
|
| 10MG | 304 | Get Quote |
|
| 25MG | 516 | Get Quote |
|
| 50MG | 737 | Get Quote |
|
| 100MG | 1017 | Get Quote |
|
| 500MG | 2052 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAM-2232
-
NoteResearch use only, not for human use.
-
Brief DescriptionAM-2232 is a potent and unselective agonist of the cannabinoid receptors.
-
DescriptionAM-2232 is a potent and unselective agonist of the cannabinoid receptors.
-
In Vitro——
-
In Vivo——
-
SynonymsAM 2232 | AM2232 | UNII-40KCH8YIKP
-
PathwayGPCR/G Protein
-
TargetCannabinoid Receptor
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number335161-19-8
-
Formula Weight352.437
-
Molecular FormulaC24H20N2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(c1cn(CCCCC#N)c2ccccc12)c1cccc2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mahmood BrobbeyOppong, et al. Secondary metabolites from Sterculia lychnophora Hance (Pangdahai). Biochemical Systematics and Ecology, Volume 92, October 2020, 104125.
molnova catalog
related products
-
LY2828360
LY2828360 is a cannabinoid (CB) receptor 2 agonist (Ki = 40.3 nM). It selectively activates CB2 over CB1 in a GTPγS binding assay (EC50s = 20.1 and >100000 nM respectively).
-
2,3-Butanediol
2,3-Butanediol is a butanediol derived from the bioconversion of natural resources which has great potential for diverse industries, including chemical, cosmetics, agriculture, and pharmaceutical areas.
-
2-Arachidonoylglycer...
2-Arachidonoylglycerol activates neuronal cannabinoid receptors as a full agonist, and prevents the induction of long-term potentiation at CA3–CA1 synapses.
